Assessment of In Vivo siRNA Delivery in Cancer Mouse Models

about

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer.Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity.

P2860

Q36768803-6BD77A5F-BF74-4CDB-A4D0-8B95DADAD670 Q37397271-F2A956C2-E1CD-4AB0-94FC-A1DD3E7EC5C1

P2860

Assessment of In Vivo siRNA Delivery in Cancer Mouse Models

Item

http://www.wikidata.org/entity/Q37481788

description

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

name

Assessment of In Vivo siRNA Delivery in Cancer Mouse Models

@en

Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.

@nl

type

Item

label

Assessment of In Vivo siRNA Delivery in Cancer Mouse Models

@en

Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.

@nl

prefLabel

Assessment of In Vivo siRNA Delivery in Cancer Mouse Models

@en

Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.

@nl

P1476

Assessment of In Vivo siRNA Delivery in Cancer Mouse Models

@en

P2093

Anil K Sood

http://www.w3.org/2001/XMLSchema#string

Gabriel Lopez-Berestein

http://www.w3.org/2001/XMLSchema#string

Lingegowda S Mangala

http://www.w3.org/2001/XMLSchema#string

Sherry Y Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Real-time quantification of microRNAs by stem-loop RT-PCR

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

Imaging of angiogenesis: from microscope to clinic.

Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer

2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.

In vivo near-infrared fluorescence imaging.

RNAi therapies: drugging the undruggable.

Functional roles of Src and Fgr in ovarian carcinoma.

P304

189-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-3378-5_15

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1402

http://www.w3.org/2001/XMLSchema#string

P50

Hiroto Hatakeyama

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26721492

http://www.w3.org/2001/XMLSchema#string

P932

5142631

http://www.w3.org/2001/XMLSchema#string

Assessment of In Vivo siRNA Delivery in Cancer Mouse Models

about

P2860

P2860

Assessment of In Vivo siRNA Delivery in Cancer Mouse Models

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932